Exposure Therapy for Veterans With PTSD and Panic Attacks (Phase 1)
NCT ID: NCT01551199
Last Updated: 2017-02-23
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE1
7 participants
INTERVENTIONAL
2012-03-31
2013-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Exposure Therapy For Veterans With PTSD And Panic Attacks
NCT01033136
Facilitating Transition to Recommended PTSD Treatment
NCT05165940
Exposure Therapy for Chronic PTSD: Efficacy and Mechanisms
NCT00475241
Telemedicine for Improved Delivery of Psychosocial Treatments for Post Traumatic Stress Disorder
NCT01158001
Group Based Exposure Therapy for Combat-Related PTSD
NCT00535223
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Multiple Channel Exposure Therapy
MCET-V is a cognitive-behavioral treatment for persons with comorbid PTSD and panic attacks
Multiple Channel Exposure Therapy- Veterans
Individual therapy design completed over a 12-week period. The treatment will include psychoeducation about panic attacks and trauma and behavioral and cognitive exposure exercises.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Multiple Channel Exposure Therapy- Veterans
Individual therapy design completed over a 12-week period. The treatment will include psychoeducation about panic attacks and trauma and behavioral and cognitive exposure exercises.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* being enrolled in the Trauma Recovery Program (TRP) at the Michael E. DeBakey Veterans Affairs Medical Center (MEDVAMC), with a current diagnosis of PTSD and PD;
* being stable on psychotropic medication for 4 weeks before study participation; and
* being at least 18 years of age.
Exclusion Criteria
* severe depression and active suicidal ideation and intent (based on Structured Clinical Interview for DSM-IV disorders \[SCID-IV\] \& Beck Depression Inventory-2nd edition \[BDI-II\]);
* cognitive impairment as indicated by the St. Louis University Mental Status exam (SLUMS); and
* veterans currently receiving psychosocial treatment specifically targeting PTSD or panic symptoms.
18 Years
64 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
VA Office of Research and Development
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ellen Teng, PhD
Role: PRINCIPAL_INVESTIGATOR
Michael E. DeBakey VA Medical Center, Houston, TX
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Michael E. DeBakey VA Medical Center, Houston, TX
Houston, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CDA2-012-09F-1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.